advertisement

---

Frontiers in pharmacology 10

Showing records 1 to 10 | Display all abstracts in Frontiers in pharmacology

100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Lambuk L
Frontiers in pharmacology 2022; 13: 875662

---

100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Li G
Frontiers in pharmacology 2022; 13: 919688

---

100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Mohd Lazaldin MA
Frontiers in pharmacology 2022; 13: 875662

---

100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Wang N; Zhang Y
Frontiers in pharmacology 2022; 13: 919688

---

100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Ahmad S; Iezhitsa I
Frontiers in pharmacology 2022; 13: 875662

---

100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Wei W; Lu H
Frontiers in pharmacology 2022; 13: 919688

---

100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Agarwal R
Frontiers in pharmacology 2022; 13: 875662

---

100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Zhai S
Frontiers in pharmacology 2022; 13: 919688

---

100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Uskoković V; Mohamud R; Mohamud R
Frontiers in pharmacology 2022; 13: 875662

---

100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Zhang C
Frontiers in pharmacology 2022; 13: 919688

---